Clinical Management of Pregnancy-Related Complications—Part II

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 1438

Special Issue Editors


E-Mail Website
Guest Editor
1. Breast Department, Rea Maternity Hospital, Pentelis, 175 64 Athens, Greece
2. Medical School, University of Montpellier-Nimes, 34090 Montpellier, France
Interests: high risk pregnancy; gynecology oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Obstetrics and Gynecology, Democritus University of Thrace, Alexandroupolis, Greece
Interests: obstetrics and gynecology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pregnancy is a unique and special period in a woman’s life. It is characterized by the presence of many alterations in the physiological and immune statuses. Several severe pregnancy-related conditions are not frequently seen in women of reproductive age. Often, various clinical specialties act in a multidisciplinary way to confront these complications. This clinical task is a difficult as well as demanding reality and endangers the lives of pregnant women and fetuses. New guidelines based on evidence-based medicine have been produced in order to minimize the frequency of these conditions. In the current Special Issue, we aim to review the pathogenesis and management of these pregnancy-related complications.

Dr. Panagiotis Peitsidis
Dr. Stephanos Zervoudis
Prof. Dr. Panagiotis Tsikouras
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes
  • hypertension
  • post-partum hemorrhage
  • preterm labor
  • infection
  • cancer

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1058 KiB  
Review
The Role of Helicobacter pylori and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes
by Maria Tzitiridou-Chatzopoulou, Evangelos Kazakos, Eirini Orovou, Paraskevi Eva Andronikidi, Foteini Kyrailidi, Maria C. Mouratidou, Georgios Iatrakis and Jannis Kountouras
J. Clin. Med. 2024, 13(8), 2360; https://doi.org/10.3390/jcm13082360 - 18 Apr 2024
Viewed by 459
Abstract
Helicobacter pylori infection, a significant global burden beyond the gastrointestinal tract, has long been implicated in various systemic pathologies. Rising evidence suggests that the bacterium’s intricate relationship with the immune system and its potential to induce chronic inflammation impact diverse pathophysiological processes in [...] Read more.
Helicobacter pylori infection, a significant global burden beyond the gastrointestinal tract, has long been implicated in various systemic pathologies. Rising evidence suggests that the bacterium’s intricate relationship with the immune system and its potential to induce chronic inflammation impact diverse pathophysiological processes in pregnant women that may in turn affect the incidence of several adverse pregnancy and neonate outcomes. Helicobacter pylori infection, which has been linked to metabolic syndrome and other disorders by provoking pericyte dysfunction, hyperhomocysteinemia, galectin-3, atrial fibrillation, gut dysbiosis, and mast cell activation pathologies, may also contribute to adverse pregnancy and neonatal outcomes. Together with increasing our biological understanding of the individual and collective involvement of Helicobacter pylori infection-related metabolic syndrome and concurrent activation of mast cells in maternal, fetus, and neonatal health outcomes, the present narrative review may foster related research endeavors to offer novel therapeutic approaches and informed clinical practice interventions to mitigate relevant risks of this critical topic among pregnant women and their offspring. Full article
(This article belongs to the Special Issue Clinical Management of Pregnancy-Related Complications—Part II)
Show Figures

Figure 1

Back to TopTop